Targeted cytotoxic analog of luteinizing hormone–releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice
- 1 May 1999
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 180 (5) , 1095-1103
- https://doi.org/10.1016/s0002-9378(99)70600-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Growth Inhibition of Human Ovarian Cancers by Cytotoxic Analogues of Luteinizing Hormone-Releasing HormoneJNCI Journal of the National Cancer Institute, 1997
- Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095Proceedings of the National Academy of Sciences, 1997
- Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.Proceedings of the National Academy of Sciences, 1996
- Down-regulation of pituitary receptors for luteinizing hormone-releasing hormone (LH-RH) in rats by LH-RH antagonist Cetrorelix.Proceedings of the National Academy of Sciences, 1996
- Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.Proceedings of the National Academy of Sciences, 1994
- Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on growth of estrogen-independent MXT mouse mammary carcinoma in vivoAnti-Cancer Drugs, 1992
- Determination of subcutaneous tumor size in athymic (nude) miceCancer Chemotherapy and Pharmacology, 1989
- A New Human Ovarian Carcinoma Cell Line: Establishment and Analysis of Tumor-Associated MarkersOncology, 1985
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980